Toshihiko Kobayashi Selected Research

Toshihiko Kobayashi Research Topics

Disease

6	Neoplasms (Cancer) 01/2013 - 07/2002
4	Thrombocytopenia (Thrombopenia) 04/2017 - 05/2009
4	Thrombotic Microangiopathies 03/2013 - 01/2008
4	Stomach Neoplasms (Stomach Cancer) 05/2007 - 01/2002
3	Thrombotic Thrombocytopenic Purpura 05/2009 - 01/2007
2	Colitis 01/2021 - 01/2021
2	Wounds and Injuries (Trauma) 04/2017 - 05/2007
2	Inflammation (Inflammations) 06/2011 - 08/2006
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2005 - 01/2005
2	Pulmonary Embolism 08/2005 - 01/2005
2	Carcinogenesis 02/2004 - 07/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 11/2019
1	Mastocytosis 11/2019
1	Carcinoma (Carcinomatosis) 01/2013
1	Lewis Lung Carcinoma 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 06/2011
1	Arthritis (Polyarthritis) 06/2011
1	Glomerulonephritis 07/2008
1	Arteritis 07/2008
1	Necrosis 04/2008
1	Rheumatoid Arthritis 04/2008
1	Sepsis (Septicemia) 11/2007
1	Lymphatic Metastasis 05/2007
1	Spasm (Spasms) 05/2007
1	Communicable Diseases (Infectious Diseases) 08/2006
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 08/2006
1	Hepatitis 04/2006
1	Breast Neoplasms (Breast Cancer) 01/2005
1	Disseminated Intravascular Coagulation 01/2005
1	Venous Thromboembolism 01/2005
1	Colorectal Neoplasms (Colorectal Cancer) 02/2004
1	Ileus 01/2004
1	Adenocarcinoma 07/2002
1	Heart Neoplasms 01/2002

Drug/Important Bio-Agent (IBA)

4	LigandsIBA 06/2011 - 07/2002
3	DisintegrinsIBA 04/2014 - 01/2007
3	Metalloproteases (Metalloproteinases)IBA 04/2014 - 01/2007
3	ThrombospondinsIBA 04/2014 - 01/2007
3	von Willebrand FactorIBA 03/2013 - 01/2008
3	thiamine triphosphorate (TTP)IBA 05/2009 - 01/2007
2	CytokinesIBA 11/2019 - 06/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 04/2006
2	Myeloblastin (Proteinase 3)IBA 04/2008 - 08/2006
2	Ephrin-A1 (Ephrin A1)IBA 01/2005 - 02/2004
2	EphA2 ReceptorIBA 01/2005 - 02/2004
2	Erythropoietin FDA Link 01/2005 - 02/2004
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	OligopeptidesIBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2019
1	Interferon Type IIBA 11/2019
1	InterferonsIBA 11/2019
1	IgE Receptors (Fc epsilon RI)IBA 11/2019
1	platelet membrane glycoprotein VIIBA 04/2017
1	Hemostatics (Antihemorrhagics)IBA 04/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	EnzymesIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Mitochondrial DNA (mtDNA)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Interleukin-4 (Interleukin 4)IBA 06/2011
1	AutoantibodiesIBA 06/2011
1	Interleukin-33IBA 06/2011
1	Urea (Carbamide)FDA LinkGeneric 07/2008
1	NitrogenIBA 07/2008
1	Infliximab (Remicade)FDA Link 04/2008
1	LipopolysaccharidesIBA 11/2007
1	C-Reactive ProteinIBA 08/2006
1	Serine Proteases (Serine Protease)IBA 08/2006
1	NF-kappa B (NF-kB)IBA 04/2006
1	GalactosamineIBA 04/2006
1	FibrinIBA 08/2005
1	fibrin fragment D (D-dimer)IBA 08/2005
1	Dacarbazine (DIC)FDA LinkGeneric 01/2005
1	Thromboplastin (Tissue Factor)IBA 01/2005
1	AntigensIBA 01/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2005
1	Messenger RNA (mRNA)IBA 01/2005
1	Thomsen-Friedenreich antigenIBA 01/2005
1	Phosphotransferases (Kinase)IBA 02/2004
1	Tyrosine (L-Tyrosine)FDA Link 02/2004
1	EphA1 Receptor (Eph Receptor)IBA 02/2004
1	EphrinsIBA 02/2004
1	S-methylisothiopseudouroniumIBA 01/2004
1	Chromogranin AIBA 01/2004
1	Glucagon (Glukagon)FDA Link 01/2004
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2004
1	Ephrin-B1 (Ephrin B1)IBA 07/2002

Therapy/Procedure

5	Liver Transplantation 04/2017 - 11/2009
2	Splenectomy 01/2016 - 04/2014
2	Gastrectomy 05/2007 - 01/2002
1	Aftercare (After-Treatment) 04/2008
1	Therapeutics 04/2008
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2007
1	Lymph Node Excision (Lymph Node Dissection) 05/2007
1	Laparotomy 01/2004